Rupture of pseudointima in an implanted vascular prosthesis: Immunohistological study of plasminogen activators and matrix metalloproteinases

Journal of Cardiovascular Surgery

Volumn 41, Issue 3, 2000, Pages 459-462

  Urayama, Hiroshi ^a   Katada, S ^a   Kasashima, F ^a   Tanaka, Y ^a   Kawasuji, M ^a   Watanabe, Y ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Anastomosis, surgical adverse effects; Blood vessel prosthesis; Metalloproteinases; Plasminogen activators; Postoperative complications; Tunica intima

Indexed keywords

COLLAGEN; COLLAGENASE; FIBRIN; GELATINASE A; GELATINASE B; MATRILYSIN; MATRIX METALLOPROTEINASE; PLASMINOGEN ACTIVATOR; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

AGED; ARTICLE; BLEEDING; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL RUPTURE; CASE REPORT; GIANT CELL; GRAFT OCCLUSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; INTIMA; LEG ISCHEMIA; MACROPHAGE; MALE; NEUTROPHIL; SPINDLE CELL;

AGED; AGED, 80 AND OVER; ANASTOMOSIS, SURGICAL; ANTIBODIES, MONOCLONAL; AORTA, ABDOMINAL; BIOLOGICAL MARKERS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMORAL ARTERY; HUMANS; IMMUNOENZYME TECHNIQUES; ISCHEMIA; LEG; MALE; MATRIX METALLOPROTEINASES; PLASMINOGEN ACTIVATORS; POSTOPERATIVE HEMORRHAGE; PROSTHESIS FAILURE; RUPTURE, SPONTANEOUS; TUNICA INTIMA; VASA VASORUM;

EID: 0033924054     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Chervu A, Moore WS. An overview of intimai hyperplasia. Surg Gynecol Obstet 1990;171:433-47.
2. Fuster V, Badimon L, Badimon J, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Eng J Med 1992;326:242-50.
3. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-503.
4. Lupu F, Heim DA, Bachmann F, Hurni M, Kakkar VV, Kruithof EKO. Plasminogen activator expression in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1995;15:1444-55.
5. Okada Y, Naka K, Kawamura K, Matsumoto T, Nakanishi I, Fujimoto N et al. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase=gelatinase B) in osteoclasts: implications for bone resorption. Lab Invest 1995;72:311-22.
6. Greisler HP, Kim DU, Price JB, Voorhees AB Jr. Arterial regenerative activity after prosthetic implantation. Arch Surg 1985;120: 315-23.
7. Sato O, Tada Y, Takagi A. The biologic fate of Dacron double velour vascular prostheses: a clinicopathological study. Jpn J Surg 1989;19:301-11.
8. Wesolow A. The healing of arterial prostheses: the state of the art. Thorac Cardiovasc Surgn 1982;30:196-208.
9. Urayama H, Kasashima F, Kawakami T, Kawakami K, Watanabe Y. An immunohistological analysis of implanted woven Dacron and expanted polytetrafluoroethylene grafts in humans. Artif Organs 1996;20:24-9.
10. Lundgren CH, Sawa H, Sobel BE, Fujii S. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy. Circulation 1994;90:1927-34.